Real-world characteristics, treatment patterns, and overall survival in patients with metastatic breast cancer (mBC) and CNS metastases

被引：0
|
作者：
Alvarado-Miranda, A. [1 ]
Cabrera-Galeana, P. [1 ]
Munoz-Montano, W. R. [1 ]
Lara-Medina, F. [1 ]
Bargallo-Rocha, E. [1 ]
Arrieta-Rodriguez, O. [1 ]
Perez, M. [1 ]
Porras-Reyes, F. [1 ]
Mohar-Betancourt, A. [1 ]
Gamboa, C. [1 ]
机构：
[1] Inst Nacl Cancerol, Mexico City, DF, Mexico
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-P1-19-07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-19-07
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Clinical characteristics, treatment patterns, and outcomes for patients with HER2-positive metastatic breast cancer (MBC) treated with pertuzumab (P) in the first-line in a real-world setting
    Robert, N.
    Goertz, H. P.
    Asmar, L.
    Tseng, W. Y.
    Jiao, X.
    Portera, C.
    Yoo, B.
    Patt, D.
    Antao, V.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S288 - S288
  • [32] Overall survival and treatment patterns among real-world patients with metastatic urothelial carcinoma treated with first-line therapy
    Simeone, Jason C.
    Nordstrom, Beth L.
    Patel, Ketan
    Klein, Alyssa B.
    Horne, Laura
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 102 - 102
  • [33] Real-world treatment in patients with HER2+metastatic breast cancer
    Colomer, R.
    Hall, P.
    Szkultecka-Debek, M.
    Bondi, R. C.
    Flinois, A.
    Auziere, S.
    Le Cleac'h, J. Y.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (01) : 197 - 205
  • [34] Treatment Patterns and Overall Survival Following Biomarker Testing in Real-World Advanced NSCLC Patients
    Barlesi, F.
    Paz-Ares, L.
    Page, D.
    Shewade, A.
    Lambert, P.
    Mughal, T.
    Gay, L.
    Khorshid, M.
    Arnieri, B.
    Capra, W.
    Foser, S.
    Mascaux, C.
    Bubendorf, L.
    Wang, L.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S459 - S460
  • [35] Real-world treatment patterns and survival among adults with metastatic breast cancer with BRCA1/2 mutations
    Bobbili, Priyanka
    Ivanova, Jasmina
    Solit, David B.
    Mettu, Niharika
    McCall, Shannon
    Dhawan, Mallika
    DerSarkissian, Maral
    Arondekar, Bhakti
    Chang, Jane
    Niyazov, Alexander
    Lee, Jocelyn
    Huq, Risha J.
    Green, Michelle
    Turski, Michelle
    Muthukumar, Aruna
    Guo, Mianzhao
    Duh, Mei Sheng
    Oh, William
    CANCER RESEARCH, 2023, 83 (05)
  • [36] REAL-WORLD PROGRESSION-FREE AND OVERALL SURVIVAL OF METASTATIC BREAST CANCER PATIENTS: ANALYSIS OF A NEW GERMAN EMR DATASET
    Wilke, T.
    Dittmar, A.
    Mueller, S.
    Juhl, H.
    VALUE IN HEALTH, 2019, 22 : S535 - S535
  • [37] Phase II study of eribulin mesylate for treatment of CNS metastases (mets) in metastatic breast cancer (mBC).
    Nelson, Ariel Ann
    Manjappa, Shivaprasad
    Choudhary, Yuvraj
    Thompson, Cheryl L.
    Agler, Jeanine
    Lawrence, Bethany
    Ahluwalia, Manmeet Singh
    Silverman, Paula
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [38] Overall survival (OS) endpoint: an incomplete evaluation of metastatic breast cancer (MBC) treatment outcome
    Raphael, Jacques
    Verma, S.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (03) : 473 - 478
  • [39] Overall survival (OS) endpoint: an incomplete evaluation of metastatic breast cancer (MBC) treatment outcome
    Jacques Raphael
    S. Verma
    Breast Cancer Research and Treatment, 2015, 150 : 473 - 478
  • [40] Real-world treatment patterns and outcomes in patients with metastatic melanoma
    Dokanovic, Dejan
    Lazic, Bojana
    Gojkovic, Zdenka
    Cvijetic, Zeljka
    Sokolovic, Emir
    Ceric, Timur
    Jungic, Sasa
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2023, 151 (3-4) : 209 - 215
12345